2009Zhōnghuá yàoxué zázhìRequires access

Pharmacokinetics and Bioequivalence of Domperidone Chewable Tablets in Healthy Volunteers

Zourong Ruan

Open publisher page 0 citations

Abstract

OBJECTIVE To study pharmacokinetics and bioequivalence of domperidone chewable tablets in healthy Chinese volunteers.METHODS A single oral dose of 10 mg tested domperidone chewable tablets or reference domperidone tablets was given to 18 healthy volunteers in a randomized crossover study.The plasma sample was deproteined by precipitation with methanol and determined by LC-MS/MS method.The pharmacokinetic and relative bioavailability were studied.RESULTS The pharmacokinetic parameters of test and reference formulations were as follows:tmax(0.59±0.29) and(0.67±0.43) h,ρmax(11.27±4.31) and(10.87±4.31) μg.L-1,t1/2(6.97±1.96) and(6.97±2.34) h,AUC0-t(37.89±13.15) and(37.54±12.53) μg.h.L-1,AUC0~∞(41.53±13.96) and(41.67±13.56) μg.h.L-1.The relative bioavailability of test to reference tablets was(102.35±21.85)%.ρmax,AUC0~t and AUC0~∞ were tested by two one-side test and analyzed for bioequivalence after log transformation of data.tmax was analyzed by Wilcoxon’s test.No significant difference was found between two preparations(P0.05).CONCLUSION The results demonstrated that the two preparations were found to be bioequivalent and thus,can be prescribed interchangeably.

About this research paper

What this paper is about

OBJECTIVE To study pharmacokinetics and bioequivalence of domperidone chewable tablets in healthy Chinese volunteers.METHODS A single oral dose of 10 mg tested domperidone chewable tablets or reference domperidone tablets was given to 18 healthy volunteers in a randomized crossover study.The plasma sample was deproteined by precipitation with methanol and determined by LC-MS/MS method.The pharmacokinetic and relative bioavailability were studied.RESULTS The pharmacokinetic parameters of test and reference formulations were as follows:tmax(0.59±0.29) and(0.67±0.43) h,ρmax(11.27±4.31) and(10.87±4.31) μg.L-1,t1/2(6.97±1.96) and(6.97±2.34) h,AUC0-t(37.89±13.15) and(37.54±12.53) μg.h.L-1,AUC0~∞(41.53±13.96) and(41.67±13.56) μg.h.L-1.The relative bioavailability of test to reference tablets was(102.35±21.85)%.ρmax,AUC0~t and AUC0~∞ were tested by two one-side test and analyzed for bioequivalence after log transformation of data.tmax was analyzed by Wilcoxon’s test.No significant difference was found between two preparations(P0.05).CONCLUSION The results demonstrated that the two preparations were found to be bioequivalent and thus,can be prescribed interchangeably.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study pharmacokinetics and bioequivalence of domperidone chewable tablets in healthy Chinese volunteers.METHODS A single oral dose of 10 mg tested domperidone chewable tablets or reference domperidone tablets was given to 18 healthy volunteers in a randomized crossover study.The plasma sample was deproteined by precipitation with methanol and determined by LC-MS/MS method.The pharmacokinetic and relative bioavailability were studied.RESULTS The pharmacokinetic parameters of test and reference formulations were as follows:tmax(0.59±0.29) and(0.67±0.43) h,ρmax(11.27±4.31) and(10.87±4.31) μg.L-1,t1/2(6.97±1.96) and(6.97±2.34) h,AUC0-t(37.89±13.15) and(37.54±12.53) μg.h.L-1,AUC0~∞(41.53±13.96) and(41.67±13.56) μg.h.L-1.The relative bioavailability of test to reference tablets was(102.35±21.85)%.ρmax,AUC0~t and AUC0~∞ were tested by two one-side test and analyzed for bioequivalence after log transformation of data.tmax was analyzed by Wilcoxon’s test.No significant difference was found between two preparations(P0.05).CONCLUSION The results demonstrated that the two preparations were found to be bioequivalent and thus,can be prescribed interchangeably.

Key concepts: Bioequivalence, Domperidone, Bioavailability, Pharmacokinetics, Crossover study, Pharmacology, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Bioequivalence of Domperidone Chewable Tablets in Healthy Volunteers — Research Paper | ScholarLens